HomeBAX • NYSE
add
Baxter International Inc
Previous close
$34.51
Day range
$34.30 - $35.24
Year range
$28.34 - $44.01
Market cap
17.78B USD
Avg Volume
5.25M
P/E ratio
-
Dividend yield
1.95%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.75B | 0.99% |
Operating expense | 844.00M | 6.84% |
Net income | -512.00M | -308.98% |
Net profit margin | -18.60 | -306.90% |
Earnings per share | 0.58 | -34.09% |
EBITDA | 524.00M | -10.73% |
Effective tax rate | 6.33% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.76B | -42.69% |
Total assets | 25.78B | -8.82% |
Total liabilities | 18.76B | -5.30% |
Total equity | 7.02B | — |
Shares outstanding | 511.62M | — |
Price to book | 2.53 | — |
Return on assets | 2.66% | — |
Return on capital | 3.35% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -512.00M | -308.98% |
Cash from operations | 488.00M | -8.10% |
Cash from investing | -205.00M | 10.87% |
Cash from financing | 141.00M | 104.80% |
Net change in cash | 334.00M | 112.88% |
Free cash flow | 590.88M | 4,580.20% |
About
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Heathcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Founded
1931
Headquarters
Website
Employees
38,000